Antimalaria drug can help treat Covid-19, study shows
A medical laboratory scientist tests vials of samples for coronavirus at the University of Washington Medicine virology lab on March 13, 2020 in Seattle, Washington. PHOTO | AFP
A research has established that an antimalarial drug shortens the time the virus remains in the bodies of Covid-19 patients with mild to moderate symptoms.
The results, published early December in the International Journal of Infectious Diseases and International Journal of Antimicrobial Agents, revealed artemisinin-piperaquine (AP) had a therapeutic effect on patients.
